525Mo Updated Efficacy and Safety of Lenvatinib (Len) + Pembrolizumab (Pembro) Vs Treatment of Physician’s Choice (Tpc) in Patients (Pts) with Advanced Endometrial Cancer (Aec): Study 309/Keynote-775

AuthID
P-00Y-B6B
20
Author(s)
Makker, V
·
Colombo, N
·
Casado Herraez, A
·
Monk, B
·
Mackay, H
·
Santin, A
·
Moore, R
·
Baron-Hay, S
·
Ray-Coquard, I
·
Shapira-Frommer, R
·
Ushijima, K
·
Yonemori, K
·
Kim, Y
·
Guerra Alia, E
·
Sanli, U
·
Huang, J
·
McKenzie, J
·
Barresi, G
·
Lorusso, D
Document Type
Article
Year published
2022
Published
in Annals of Oncology, ISSN: 0923-7534
Volume: 33, Pages: S785-S786
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.